Table 3.
MBSR mean |
WLC mean |
p value | Effect size |
|
---|---|---|---|---|
MAAS scores | ||||
Baseline | 5.08 | 5.30 | 0.017 | −0.29 |
8 weeks | 5.21 | 5.28 | 0.500 | −0.08 |
11 weeks | 5.53 | 5.39 | 0.153 | 0.18 |
32 weeks | 5.46 | 5.27 | 0.023 | 0.25 |
Trails B/A ratio | ||||
Baseline | 2.01 | 1.89 | 0.281 | −0.06 |
8 weeks | 1.75 | 2.01 | 0.04 | − 0.24 |
11 weeks | 2.37 | 2.43 | 0.666 | 0.05 |
32 weeks | 1.89 | 1.98 | 0.507 | 0.08 |
IgG (absorbance) | ||||
8 weeks | 0.172 | 0.104 | 0.007 | 0.18 |
11 weeks | 0.203 | 0.256 | 0.293 | −0.14 |
32 weeks | 0.143 | 0.223 | 0.036 | − 0.22 |
Group differences with p < 0.05 are in italics. Week 8 = Immediately after intervention, at the time of KLH challenge. Effect size is Cohen's d and is the difference between treatment and control group at each time point, expressed in standard deviation units; analyses are adjusted for MAAS, CES-D, and PSS scores at baseline.